首页 > 最新文献

Expert Review of Respiratory Medicine最新文献

英文 中文
Non-invasive respiratory support in elderly hospitalized patients. 老年住院病人的无创呼吸支持。
IF 3.9 3区 医学 Q2 RESPIRATORY SYSTEM Pub Date : 2024-09-19 DOI: 10.1080/17476348.2024.2404696
Silvia Coppola,Dejan Radovanovic,Tommaso Pozzi,Fiammetta Danzo,Cosmo Rocco,Giada Lazzaroni,Pierachille Santus,Davide Chiumello
INTRODUCTIONThe proportion of elderly people among hospitalized patients is rapidly growing. Between 7% to 25% of ICU patients are aged 85 and over and noninvasive respiratory support is often offered to avoid the risks of invasive mechanical ventilation or in patients with a 'do-not-intubate' order. However, while noninvasive respiratory support has been extensively studied in the general population, there is limited data available on its efficacy in elderly patients with ARF.AREAS COVEREDPubMed/Medline, Web of Science, Scopus and Embase online databases were searched for studies that assessed clinical efficacy of high flow nasal cannula, continuous positive airway pressure and noninvasive ventilation in patients ≥ 65 years old with acute de novo ARF, showing that short to mid-term benefits provided by noninvasive respiratory support in elderly patients in terms of reduction of mechanical ventilation risk and mortality are similar to younger patients, if adjusted for the severity of comorbidities and respiratory failure.EXPERT OPINIONNoninvasive support strategies can represent an effective opportunity in elderly patients with ARF, especially in patients too frail to undergo endotracheal intubation and in whom received or decided for a 'do not intubate' order. Indeed, noninvasive support has a different impact, depending on the setting.
引言 住院病人中老年人的比例正在迅速增长。7% 至 25% 的重症监护病房患者年龄在 85 岁及以上,为了避免有创机械通气的风险,或对于 "不插管 "的患者,通常会提供无创呼吸支持。然而,虽然无创呼吸支持已在普通人群中进行了广泛研究,但有关其在 ARF 老年患者中疗效的数据却很有限。搜索了PubMed/Medline、Web of Science、Scopus 和 Embase 在线数据库中评估高流量鼻插管、持续气道正压和无创通气对年龄≥ 65 岁的急性新发 ARF 患者临床疗效的研究,结果表明,如果根据合并症和呼吸衰竭的严重程度进行调整,无创呼吸支持对老年患者在降低机械通气风险和死亡率方面的中短期益处与年轻患者相似。专家观点无创支持策略对于患有 ARF 的老年患者来说是一个有效的机会,尤其是对于过于虚弱而无法进行气管插管的患者,以及接受或决定接受 "不插管 "指令的患者。事实上,无创支持会根据不同的环境产生不同的影响。
{"title":"Non-invasive respiratory support in elderly hospitalized patients.","authors":"Silvia Coppola,Dejan Radovanovic,Tommaso Pozzi,Fiammetta Danzo,Cosmo Rocco,Giada Lazzaroni,Pierachille Santus,Davide Chiumello","doi":"10.1080/17476348.2024.2404696","DOIUrl":"https://doi.org/10.1080/17476348.2024.2404696","url":null,"abstract":"INTRODUCTIONThe proportion of elderly people among hospitalized patients is rapidly growing. Between 7% to 25% of ICU patients are aged 85 and over and noninvasive respiratory support is often offered to avoid the risks of invasive mechanical ventilation or in patients with a 'do-not-intubate' order. However, while noninvasive respiratory support has been extensively studied in the general population, there is limited data available on its efficacy in elderly patients with ARF.AREAS COVEREDPubMed/Medline, Web of Science, Scopus and Embase online databases were searched for studies that assessed clinical efficacy of high flow nasal cannula, continuous positive airway pressure and noninvasive ventilation in patients ≥ 65 years old with acute de novo ARF, showing that short to mid-term benefits provided by noninvasive respiratory support in elderly patients in terms of reduction of mechanical ventilation risk and mortality are similar to younger patients, if adjusted for the severity of comorbidities and respiratory failure.EXPERT OPINIONNoninvasive support strategies can represent an effective opportunity in elderly patients with ARF, especially in patients too frail to undergo endotracheal intubation and in whom received or decided for a 'do not intubate' order. Indeed, noninvasive support has a different impact, depending on the setting.","PeriodicalId":12103,"journal":{"name":"Expert Review of Respiratory Medicine","volume":"19 1","pages":"1-16"},"PeriodicalIF":3.9,"publicationDate":"2024-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142252226","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Overcoming challenges of managing chronic obstructive pulmonary disease in low- and middle-income countries 克服中低收入国家在管理慢性阻塞性肺病方面的挑战
IF 3.9 3区 医学 Q2 RESPIRATORY SYSTEM Pub Date : 2024-09-16 DOI: 10.1080/17476348.2024.2398639
Patricia Alupo, Joseph Baluku, Felix Bongomin, Trishul Siddharthan, Winceslaus Katagira, Ahmed Ddungu, John R. Hurst, Job F. M. van Boven, William Worodria, Bruce J. Kirenga
Chronic obstructive pulmonary disease (COPD) ranks among the top three global causes of death, with 90% of fatalities concentrated in low- and middle-income countries (LMICs). The projected rise in...
慢性阻塞性肺病 (COPD) 是全球三大死亡原因之一,其中 90% 的死亡病例集中在中低收入国家 (LMIC)。预计全球慢性阻塞性肺病(COPD)的发病率将上升。
{"title":"Overcoming challenges of managing chronic obstructive pulmonary disease in low- and middle-income countries","authors":"Patricia Alupo, Joseph Baluku, Felix Bongomin, Trishul Siddharthan, Winceslaus Katagira, Ahmed Ddungu, John R. Hurst, Job F. M. van Boven, William Worodria, Bruce J. Kirenga","doi":"10.1080/17476348.2024.2398639","DOIUrl":"https://doi.org/10.1080/17476348.2024.2398639","url":null,"abstract":"Chronic obstructive pulmonary disease (COPD) ranks among the top three global causes of death, with 90% of fatalities concentrated in low- and middle-income countries (LMICs). The projected rise in...","PeriodicalId":12103,"journal":{"name":"Expert Review of Respiratory Medicine","volume":"65 1","pages":""},"PeriodicalIF":3.9,"publicationDate":"2024-09-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142252227","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Understanding the impact of breathing pattern disorders in difficult-to-treat asthma 了解呼吸模式紊乱对难治性哮喘的影响
IF 3.9 3区 医学 Q2 RESPIRATORY SYSTEM Pub Date : 2024-09-16 DOI: 10.1080/17476348.2024.2404673
J. J. Hudson-Colby, Adam Lewis, Judit Varkonyi-Sepp, Ben Ainsworth, Anna Freeman, Anneliese Day, Ratko Djukanovic, Liuyu Wei, Hans Michael Haitchi, Ramesh J. Kurukulaaratchy
Difficult-to-treat asthma is defined as asthma that is uncontrolled despite high-level treatment or requires such treatment to maintain good control and reduce exacerbations. Breathing pattern diso...
难以治疗的哮喘是指在接受高级治疗后仍无法控制的哮喘,或者需要接受高级治疗才能保持良好的控制并减少病情恶化。呼吸模式失调是哮喘的主要特征之一。
{"title":"Understanding the impact of breathing pattern disorders in difficult-to-treat asthma","authors":"J. J. Hudson-Colby, Adam Lewis, Judit Varkonyi-Sepp, Ben Ainsworth, Anna Freeman, Anneliese Day, Ratko Djukanovic, Liuyu Wei, Hans Michael Haitchi, Ramesh J. Kurukulaaratchy","doi":"10.1080/17476348.2024.2404673","DOIUrl":"https://doi.org/10.1080/17476348.2024.2404673","url":null,"abstract":"Difficult-to-treat asthma is defined as asthma that is uncontrolled despite high-level treatment or requires such treatment to maintain good control and reduce exacerbations. Breathing pattern diso...","PeriodicalId":12103,"journal":{"name":"Expert Review of Respiratory Medicine","volume":"75 1","pages":""},"PeriodicalIF":3.9,"publicationDate":"2024-09-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142252342","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Omics research in lymphangioleiomyomatosis: status and challenges. 淋巴管瘤病的 Omics 研究:现状与挑战。
IF 3.9 3区 医学 Q2 RESPIRATORY SYSTEM Pub Date : 2024-09-11 DOI: 10.1080/17476348.2024.2403498
Xinhe Zhang,Song Liu,Luning Yang,Chongsheng Cheng,Hanghang Wang,Danjing Hu,Xiaoxin Zhang,Miaoyan Zhang,Yaping Liu,Xinlun Tian,Hongbing Zhang,Kai-Feng Xu
INTRODUCTIONLymphangioleiomyomatosis (LAM) is a rare and progressive disorder that usually arises in the lung and almost exclusively affects women of childbearing age. In recent years, a number of molecules have been shown to be differentially expressed between patients with LAM and healthy control individuals, and some of these molecules, in addition to vascular endothelial growth factor D (VEGF-D), have the potential to be novel biomarkers.AREAS COVEREDThis review summarizes the recent advances in omics research, including genomics, transcriptomics, proteomics, and metabolomics, in LAM biomarker discovery. It also retrieves the literature on LAM biomarkers studied by omics techniques in the last ten years using PubMed and other retrieval tools.EXPERT OPINIONFurther research on expanded sample sizes can be conducted to construct specific models to study the role of these molecules in the pathogenesis of LAM and clarify the underlying mechanisms involved. In the future, in terms of technology, the combination of various omics methods is expected to result in novel biomarker discovery.
导言淋巴管瘤(LAM)是一种罕见的进行性疾病,通常发生在肺部,几乎只影响育龄妇女。近年来,一些分子被证明在 LAM 患者和健康对照者之间有差异表达,其中一些分子,除了血管内皮生长因子 D (VEGF-D),还有可能成为新型生物标记物。专家观点可以通过扩大样本量开展进一步研究,构建特定模型来研究这些分子在 LAM 发病机制中的作用,并阐明相关的潜在机制。未来,在技术方面,各种 omics 方法的结合有望发现新的生物标记物。
{"title":"Omics research in lymphangioleiomyomatosis: status and challenges.","authors":"Xinhe Zhang,Song Liu,Luning Yang,Chongsheng Cheng,Hanghang Wang,Danjing Hu,Xiaoxin Zhang,Miaoyan Zhang,Yaping Liu,Xinlun Tian,Hongbing Zhang,Kai-Feng Xu","doi":"10.1080/17476348.2024.2403498","DOIUrl":"https://doi.org/10.1080/17476348.2024.2403498","url":null,"abstract":"INTRODUCTIONLymphangioleiomyomatosis (LAM) is a rare and progressive disorder that usually arises in the lung and almost exclusively affects women of childbearing age. In recent years, a number of molecules have been shown to be differentially expressed between patients with LAM and healthy control individuals, and some of these molecules, in addition to vascular endothelial growth factor D (VEGF-D), have the potential to be novel biomarkers.AREAS COVEREDThis review summarizes the recent advances in omics research, including genomics, transcriptomics, proteomics, and metabolomics, in LAM biomarker discovery. It also retrieves the literature on LAM biomarkers studied by omics techniques in the last ten years using PubMed and other retrieval tools.EXPERT OPINIONFurther research on expanded sample sizes can be conducted to construct specific models to study the role of these molecules in the pathogenesis of LAM and clarify the underlying mechanisms involved. In the future, in terms of technology, the combination of various omics methods is expected to result in novel biomarker discovery.","PeriodicalId":12103,"journal":{"name":"Expert Review of Respiratory Medicine","volume":"60 1","pages":""},"PeriodicalIF":3.9,"publicationDate":"2024-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142193475","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A clinician's guide to effects of obesity on childhood asthma and into adulthood. 肥胖对儿童哮喘和成年期影响的临床医生指南。
IF 3.9 3区 医学 Q2 RESPIRATORY SYSTEM Pub Date : 2024-09-11 DOI: 10.1080/17476348.2024.2403500
Mahmoud Abu Zahra,Jeffrey Pessin,Deepa Rastogi
INTRODUCTIONObesity, one of the most common chronic conditions affecting the human race globally, affects several organ systems, including the respiratory system, where it contributes to onset and high burden of asthma. Childhood onset of obesity-related asthma is associated with high persistent morbidity into adulthood.AREAS COVEREDIn this review, we discuss the disease burden in children and adults to highlight the overlap between symptoms and pulmonary function deficits associated with obesity-related asthma in both age ranges, and then discuss the potential role of three distinct mechanisms, that of mechanical fat load, immune perturbations, and of metabolic perturbations on the disease burden. We also discuss interventions, including medical interventions for weight loss such as diet modification, that of antibiotics and anti-inflammatory therapies, as well as that of surgical intervention on amelioration of burden of obesity-related asthma.EXPERT OPINIONWith increase in obesity-related asthma due to increasing burden of obesity, it is evident that it is a disease entity distinct from asthma among lean individuals. The time is ripe to investigate the underlying mechanisms, focusing on identifying novel therapeutic targets as well as consideration to repurpose medications effective for other obesity-mediated complications, such as insulin resistance, dyslipidemia and systemic inflammation.
导言肥胖是影响全球人类最常见的慢性疾病之一,会影响包括呼吸系统在内的多个器官系统,导致哮喘的发病和高负担。在这篇综述中,我们讨论了儿童和成人的疾病负担,强调了这两个年龄段与肥胖相关的哮喘的症状和肺功能缺陷之间的重叠,然后讨论了三种不同机制对疾病负担的潜在作用,即机械性脂肪负荷、免疫扰动和代谢扰动。我们还讨论了干预措施,包括减肥药物干预(如饮食调整)、抗生素和抗炎疗法,以及手术干预对减轻肥胖相关性哮喘负担的作用。研究其潜在机制的时机已经成熟,重点是确定新的治疗靶点,并考虑重新使用对其他肥胖介导的并发症(如胰岛素抵抗、血脂异常和全身炎症)有效的药物。
{"title":"A clinician's guide to effects of obesity on childhood asthma and into adulthood.","authors":"Mahmoud Abu Zahra,Jeffrey Pessin,Deepa Rastogi","doi":"10.1080/17476348.2024.2403500","DOIUrl":"https://doi.org/10.1080/17476348.2024.2403500","url":null,"abstract":"INTRODUCTIONObesity, one of the most common chronic conditions affecting the human race globally, affects several organ systems, including the respiratory system, where it contributes to onset and high burden of asthma. Childhood onset of obesity-related asthma is associated with high persistent morbidity into adulthood.AREAS COVEREDIn this review, we discuss the disease burden in children and adults to highlight the overlap between symptoms and pulmonary function deficits associated with obesity-related asthma in both age ranges, and then discuss the potential role of three distinct mechanisms, that of mechanical fat load, immune perturbations, and of metabolic perturbations on the disease burden. We also discuss interventions, including medical interventions for weight loss such as diet modification, that of antibiotics and anti-inflammatory therapies, as well as that of surgical intervention on amelioration of burden of obesity-related asthma.EXPERT OPINIONWith increase in obesity-related asthma due to increasing burden of obesity, it is evident that it is a disease entity distinct from asthma among lean individuals. The time is ripe to investigate the underlying mechanisms, focusing on identifying novel therapeutic targets as well as consideration to repurpose medications effective for other obesity-mediated complications, such as insulin resistance, dyslipidemia and systemic inflammation.","PeriodicalId":12103,"journal":{"name":"Expert Review of Respiratory Medicine","volume":"446 1","pages":""},"PeriodicalIF":3.9,"publicationDate":"2024-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142225015","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Thoracic ultrasound in guiding management of respiratory disease 胸腔超声在呼吸系统疾病治疗中的指导作用
IF 3.9 3区 医学 Q2 RESPIRATORY SYSTEM Pub Date : 2024-08-03 DOI: 10.1080/17476348.2024.2387785
Maged Hassan, Sally Griffiths, Ben Probyn, Ahmed S Sadaka, Abdelfattah A Touman, Gareth Trevelyan, David Breen, Cyrus Daneshvar
Theuse of ultrasound in respiratory disease has evolved substantially over thepast two decades. From a test done to confirm the safe site of pleural fluiddrainage, thoracic ultrasound has become a ...
过去二十年来,超声波在呼吸系统疾病中的应用有了长足的发展。从最初用于确认胸腔积液引流安全部位的检查,到如今胸腔超声已成为一种 ...
{"title":"Thoracic ultrasound in guiding management of respiratory disease","authors":"Maged Hassan, Sally Griffiths, Ben Probyn, Ahmed S Sadaka, Abdelfattah A Touman, Gareth Trevelyan, David Breen, Cyrus Daneshvar","doi":"10.1080/17476348.2024.2387785","DOIUrl":"https://doi.org/10.1080/17476348.2024.2387785","url":null,"abstract":"Theuse of ultrasound in respiratory disease has evolved substantially over thepast two decades. From a test done to confirm the safe site of pleural fluiddrainage, thoracic ultrasound has become a ...","PeriodicalId":12103,"journal":{"name":"Expert Review of Respiratory Medicine","volume":"35 1","pages":""},"PeriodicalIF":3.9,"publicationDate":"2024-08-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141880486","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Relationship between obstructive sleep apnea and pulmonary hypertension: past, present and future 阻塞性睡眠呼吸暂停与肺动脉高压之间的关系:过去、现在和未来
IF 3.9 3区 医学 Q2 RESPIRATORY SYSTEM Pub Date : 2024-04-22 DOI: 10.1080/17476348.2024.2345684
Jyotirmayee Lenka, Raymond Foley, Mark Metersky, Adrian Salmon
Obstructive sleep apnea (OSA) is a widely prevalent condition with consequent multiple organ systems complications. There is consensus that OSA is associated with negative effects on pulmonary hemo...
阻塞性睡眠呼吸暂停(OSA)是一种广泛流行的疾病,会引起多个器官系统的并发症。目前的共识是,OSA 会对肺部血液循环和呼吸系统产生负面影响。
{"title":"Relationship between obstructive sleep apnea and pulmonary hypertension: past, present and future","authors":"Jyotirmayee Lenka, Raymond Foley, Mark Metersky, Adrian Salmon","doi":"10.1080/17476348.2024.2345684","DOIUrl":"https://doi.org/10.1080/17476348.2024.2345684","url":null,"abstract":"Obstructive sleep apnea (OSA) is a widely prevalent condition with consequent multiple organ systems complications. There is consensus that OSA is associated with negative effects on pulmonary hemo...","PeriodicalId":12103,"journal":{"name":"Expert Review of Respiratory Medicine","volume":"1 1","pages":""},"PeriodicalIF":3.9,"publicationDate":"2024-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140636881","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Why don’t anti-inflammatories work in cystic fibrosis? 为什么消炎药对囊性纤维化无效?
IF 3.9 3区 医学 Q2 RESPIRATORY SYSTEM Pub Date : 2024-02-22 DOI: 10.1080/17476348.2024.2323189
Michelle Casey, Nicholas J Simmonds
Published in Expert Review of Respiratory Medicine (Just accepted, 2024)
发表于《呼吸医学专家评论》(刚刚接受,2024 年)
{"title":"Why don’t anti-inflammatories work in cystic fibrosis?","authors":"Michelle Casey, Nicholas J Simmonds","doi":"10.1080/17476348.2024.2323189","DOIUrl":"https://doi.org/10.1080/17476348.2024.2323189","url":null,"abstract":"Published in Expert Review of Respiratory Medicine (Just accepted, 2024)","PeriodicalId":12103,"journal":{"name":"Expert Review of Respiratory Medicine","volume":"1 1","pages":""},"PeriodicalIF":3.9,"publicationDate":"2024-02-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139921823","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mild asthma is not mild: Risk factors and predictive biomarkers for severe acute exacerbations and progression in mild asthma 轻度哮喘并不轻: 轻度哮喘严重急性加重和恶化的风险因素和预测性生物标志物
IF 3.9 3区 医学 Q2 RESPIRATORY SYSTEM Pub Date : 2024-02-05 DOI: 10.1080/17476348.2024.2314535
Lingling Wang, Ling zhou, Pengdou Zheng, Zhenyu Mao, Huiguo Liu
Asthma is a common chronic respiratory disease characterized by chronic airway inflammation, airway hyperresponsiveness, reversible airflow limitation, and airway remodeling. Mild asthma is the mos...
哮喘是一种常见的慢性呼吸道疾病,以慢性气道炎症、气道高反应性、可逆性气流受限和气道重塑为特征。轻度哮喘是最常见的...
{"title":"Mild asthma is not mild: Risk factors and predictive biomarkers for severe acute exacerbations and progression in mild asthma","authors":"Lingling Wang, Ling zhou, Pengdou Zheng, Zhenyu Mao, Huiguo Liu","doi":"10.1080/17476348.2024.2314535","DOIUrl":"https://doi.org/10.1080/17476348.2024.2314535","url":null,"abstract":"Asthma is a common chronic respiratory disease characterized by chronic airway inflammation, airway hyperresponsiveness, reversible airflow limitation, and airway remodeling. Mild asthma is the mos...","PeriodicalId":12103,"journal":{"name":"Expert Review of Respiratory Medicine","volume":"305 1","pages":""},"PeriodicalIF":3.9,"publicationDate":"2024-02-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139689331","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Indications and evidence for domiciliary noninvasive ventilation 家用无创通气的适应症和证据
IF 3.9 3区 医学 Q2 RESPIRATORY SYSTEM Pub Date : 2023-12-19 DOI: 10.1080/17476348.2023.2295941
Anita Saigal, Amar J Shah, Swapna Mandal
Home noninvasive ventilation (HNIV) has expanded globally, with a greater evidence base for its’ use. HNIV improves multiple patient related outcomes in patients with chronic hypercapnic respirator...
家用无创通气(HNIV)已在全球范围内得到推广,其使用也有了更多的证据基础。家用无创通气(HNIV)可改善慢性高碳酸血症呼吸机患者的多种相关预后。
{"title":"Indications and evidence for domiciliary noninvasive ventilation","authors":"Anita Saigal, Amar J Shah, Swapna Mandal","doi":"10.1080/17476348.2023.2295941","DOIUrl":"https://doi.org/10.1080/17476348.2023.2295941","url":null,"abstract":"Home noninvasive ventilation (HNIV) has expanded globally, with a greater evidence base for its’ use. HNIV improves multiple patient related outcomes in patients with chronic hypercapnic respirator...","PeriodicalId":12103,"journal":{"name":"Expert Review of Respiratory Medicine","volume":"33 1","pages":""},"PeriodicalIF":3.9,"publicationDate":"2023-12-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138818448","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Expert Review of Respiratory Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1